Linked Life Data

11193920

Source:http://linkedlifedata.com/resource/pubmed/id/11193920

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2001-1-18
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0077-8923
pubmed:author
pubmed:issnType
Print
pubmed:volume
922
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
349-51
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Phase II study of intravenous DX-8951f in patients with advanced ovarian, tubal, or peritoneal cancer refractory to platinum, taxane, and topotecan.
pubmed:affiliation
Secion of Gynecologic and Medical Therapeutics, Department of Gynecology Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. cverschr@mdanderson.org
pubmed:publicationType
Journal Article, Clinical Trial, Clinical Trial, Phase II